Tauriga Sciences Inc. announced it has signed a non-exclusive licensing agreement with Targeted Medical Pharma Inc. to reformulate and rebrand Targeted Medical's medical food formulations into dietary supplements as part of Tauriga's "Cannabis Complements" product line. Tauriga's new Cannabis Complements product line will be formally launched later in the summer and consists of dietary supplements and other natural wellness products that do not contain cannabis oil and that will attempt to address cannabis-related effects, such as anxiety, memory and cognitive functions, and appetite control. The products to be offered under the "Cannabis Complements" line will contain "GRAS" ingredients, the U.S. Food and Drug Administration's designation for ingredients that are "Generally Recognized as Safe".

The initial products Tauriga plans to introduce under the Cannabis Complements line are Satietiva, an appetite suppressant, and Indicalm, an antiolytic supplement for anxiety. These products are not limited to cannabis-related effects but will be introduced to address the concerns of the demographic.